11-78566139-A-C

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_024678.6(NARS2):​c.506T>G​(p.Phe169Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,453,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F169Y) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

NARS2
NM_024678.6 missense

Scores

7
10
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.30

Publications

4 publications found
Variant links:
Genes affected
NARS2 (HGNC:26274): (asparaginyl-tRNA synthetase 2, mitochondrial) This gene encodes a putative member of the class II family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of asparagine to tRNA molecules. Mutations in this gene have been associated with combined oxidative phosphorylation deficiency 24 (COXPD24). [provided by RefSeq, Mar 2015]
NARS2 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 24
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: Illumina
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive 94
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.97

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024678.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NARS2
NM_024678.6
MANE Select
c.506T>Gp.Phe169Cys
missense
Exon 4 of 14NP_078954.4
NARS2
NM_001425310.1
c.-176T>G
5_prime_UTR_premature_start_codon_gain
Exon 4 of 15NP_001412239.1
NARS2
NM_001425311.1
c.-51T>G
5_prime_UTR_premature_start_codon_gain
Exon 4 of 13NP_001412240.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NARS2
ENST00000281038.10
TSL:1 MANE Select
c.506T>Gp.Phe169Cys
missense
Exon 4 of 14ENSP00000281038.5
NARS2
ENST00000528850.5
TSL:5
c.-176T>G
5_prime_UTR_premature_start_codon_gain
Exon 4 of 14ENSP00000432635.1
NARS2
ENST00000695115.1
c.-268T>G
5_prime_UTR_premature_start_codon_gain
Exon 4 of 15ENSP00000511705.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000408
AC:
1
AN:
244944
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000895
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1453560
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
722758
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33074
American (AMR)
AF:
0.00
AC:
0
AN:
43156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39568
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84524
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53216
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5738
European-Non Finnish (NFE)
AF:
0.00000271
AC:
3
AN:
1108474
Other (OTH)
AF:
0.00
AC:
0
AN:
60024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 19, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.506T>G (p.F169C) alteration is located in exon 4 (coding exon 4) of the NARS2 gene. This alteration results from a T to G substitution at nucleotide position 506, causing the phenylalanine (F) at amino acid position 169 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.84
D
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.92
D
M_CAP
Uncertain
0.12
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Uncertain
0.47
D
MutationAssessor
Pathogenic
4.0
H
PhyloP100
3.3
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-7.4
D
REVEL
Pathogenic
0.81
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.69
MutPred
0.89
Loss of stability (P = 0.0053)
MVP
0.92
MPC
0.34
ClinPred
1.0
D
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.92
gMVP
0.78
Mutation Taster
=50/50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144653284; hg19: chr11-78277185; API